Alterity Therapeutics Financials
| PRNAF Stock | USD 0 0.00 0.00% |
Alterity |
Understanding current and past Alterity Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Alterity Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Alterity Therapeutics' assets may result in an increase in income on the income statement.
Alterity Therapeutics Stock Summary
Alterity Therapeutics competes with Genprex, Reviva Pharmaceuticals, Greenwich Lifesciences, Cognition Therapeutics, and Galectin Therapeutics. Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimers disease, Huntington disease, Parkinsons disease, and other neurological disorders in Australia. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. Prana Biotechnology operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 12 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 460 Bourke Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | alteritytherapeutics.com |
| Phone | 61 3 9349 4906 |
| Currency | USD - US Dollar |
Alterity Therapeutics Key Financial Ratios
There are many critical financial ratios that Alterity Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Alterity Therapeutics reports annually and quarterly.| Return On Equity | -0.39 | |||
| Return On Asset | -0.26 | |||
| Number Of Employees | 12 | |||
| Beta | 0.87 | |||
| Z Score | 91.2 |
Alterity Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alterity Therapeutics's current stock value. Our valuation model uses many indicators to compare Alterity Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alterity Therapeutics competition to find correlations between indicators driving Alterity Therapeutics's intrinsic value. More Info.Alterity Therapeutics Limited is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alterity Therapeutics' earnings, one of the primary drivers of an investment's value.Alterity Therapeutics Systematic Risk
Alterity Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Alterity Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Alterity Therapeutics correlated with the market. If Beta is less than 0 Alterity Therapeutics generally moves in the opposite direction as compared to the market. If Alterity Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Alterity Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Alterity Therapeutics is generally in the same direction as the market. If Beta > 1 Alterity Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Alterity Pink Sheet analysis
When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |